logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
L

Lin Wu

the affiliated cancer hospital of xiangya school of medicine

59H-index
470Paper Count
1.7WCitation Count
Published Papers 147
Publication Date
logo
Real-world evidence of immunotherapy in older adults with advanced non-small cell lung cancer: a retrospective cohort study
errCancer Immunology Immunotherapy
IF5.1
err2026-08-07
err0
errOAAI
errYuling Zhong; Jingyi Wang; Bolin Chen; Yan Xu; Li Xu; Jia Li; Fang Xu; Qianzhi Wang; Kang Li; Yi Kong; Liyu Liu; Yini Liang; Mei Peng; Lin Wu
errShare
errSave
Real-world serplulimab plus chemotherapy for extensive-stage small cell lung cancer in china: an external validation of ASTRUM-005 trial
errBMC Medicine
IF8.3
err2026-07-15
err0
errOAAI
errLin Wu; Chengping Hu; Wenzhong Su; Hui Zhu; Wei Hong; Haichuan Su; Yan Yu; Tao Luo; Zhigang Liu; Zhentian Liu; Qing Pu; Caixia Wang; Xuhong Min; Hui Guo; Yifei Chen
errShare
errSave
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial
errNature Medicine
IF50
err2026-03-27
err0
errOAAI
errByoung Chul Cho; Rama Balaraman; Hua-Jun Chen; Xinmin Yu; Adewale Fawole; Zhi-gang Liu; Jiliang Zhang; Long Wu; Bin Yang; Jennifer L. Leddon; John Hamm; Yanjing Huang; Lin Wu; Pinhua Pan; Preet Singh; Andrew Beardsley; Fadi Kayali; Ardalan Davarifar; Ki Hyeong Lee; Keon-Uk Park; Youngjoo Lee; Luchun Li; Xicheng Wang; Meili Sun; Yan Yu; Vikram Jain; Svetlana Shpyro; Qiong Wang; Michael Wenger; Uğur Şahin; Sergey Efuni; Shiling Song; Kun He; Pan Zheng; Yang Liu; Kai He; Tianhong Li; Mark A. Socinski; Yi-Long Wu
errShare
errSave
First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFR-mutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial
errSignal Transduction and Targeted Therapy
IF52.7
err2026-02-02
err0
errOAAI
errFan Zhang; Zhendong Zheng; Hongmei Zhang; Xiaolong Yan; Zhefeng Liu; Fan Yang; Juyi Wen; Xin Gan; Lin Wu; Shundong Cang; Hongmei Wang; Jun Zhao; Liang Peng; Xiaosong Li; Zaiwen Fan; Ge Shen; Qiong Zhou; Jinjing Zou; Yu Xu; Lei Zhang; Mingfang Zhao; Shangli Cai; Yi Hu
errShare
errSave
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy
errJournal of Hematology & Oncology
IF40.4
err2025-12-07
err0
errOAAI
errYi-Long Wu; Lin Wu; Nan Bi; Timucin Cil; Hong Ge; Zhengfei Zhu; Chih-Liang Wang; Wei Zhang; Dongqing Lv; E. Mingyan; Jianguo Sun; Yi Pan; Maciej Krzakowski; Mustafa Dikilitas; Mehmet Ali Nahit Sendur; Young-Chul Kim; Yanjiao Yang; Rui Mao; Biao Zhang; Luhua Wang
errShare
errSave
Stiffness-Tunable Hydrogel Microfluidic Chip Reveals the Role of Stiffness in Cholangiocarcinoma Invasion and Pre-Metastatic Niche Formation
errAdvanced Healthcare Materials
IF9.6
err2025-11-30
err0
PREAI
errLin Wu; Guohua Wu; Di Wu; Wenqi Hu; Qijun Du; Qinrui Lu; Jiashu Wang; Ao Xie; Youlong Yang; Jie Liu; Wenlong Zhang; Chengwei Sun; Bangchuan Hu; Zipeng Yao; Hongbin Deng; Mengjiao Xia; Haijie Hu; Shuqi Wang
errShare
errSave
Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation–positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA study
errLung Cancer
IF4.4
err2025-11-25
err0
PREAI
errLin Wu; Junling Li; Chong-Rui Xu; Bivas Biswas; Somnath Roy; Ke-Jing Tang; Huijuan Wang; Ziling Liu; Ullas Batra; Gwo Fuang Ho; John Low Seng Hooi; You Lu; Mingfang Zhao; Lye Mun Tho; Jun Zhao; Shan He; Joan Huang; Hui Zhang; Chew Hooi Wong; Yi-Long Wu
errShare
errSave
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
errCancer Cell
IF44.5
err2025-10-23
err0
PREAI
errJia Zhong; Lin Wu; Zhengbo Song; Nianzeng Xing; Jiujie Cui; Xingya Li; Kailun Fei; Dihong Tang; Qi Dang; Liang Chen; Tianshu Liu; Caigang Liu; Yong Li; Shichuan Zhang; Xinghua Han; Juxiang Xiao; Feng Guo; Min Yan; Huiting Xu; Chunxiu Yuan; Jincai Zhong; Rongrui Liu; Xiujuan Qu; Shikai Wu; Shusuan Jiang; Yan Yang; Panpan Zhang; Hongqian Guo; Ce Wang; Qiushi Xie; Zhifei Lin; Shuni Wang; Jie Wang
errShare
errSave
Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials
errCancer Communications
IF24.9
err2025-10-02
err0
errOAAI
errJian Li; Ting Deng; Yanhong Gu; Antonio Calles Blanco; Zhihua Li; Chunmei Bai; Lin Wu; Jing Huang; Xingya Li; Yu Yao; Zhengbo Song; Yongsheng Li; Lian Liu; Ligang Xing; Wenming Wu; Julia Martínez-Pérez; Ayala Hubert; Jon Zugazagoitia; Jian Zhang; Yongsheng Wang; Yanqiu Zhao; Guilan Wen; Guohao Xia; Diansheng Zhong; Xueqin Chen; Kuirong Jiang; Andrea Wang-Gillam; Yuli Ding; Sumei Liu; Zhiyue Rao; Xinghu Liu; Lin Shen
errShare
errSave
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-10-01
err4
PREAI
errLe, Xiuning; Kim, Tae Min; Loong, Herbert H.; Prelaj, Arsela; Goh, Boon Cher; Li, Lin; Fang, Yong; Lu, Shun; Dong, Xiaorong; Wu, Lin; Shinno, Yuki; Daniele, Gennaro; Yang, Tsung-Ying; Kim, Hye Ryun; Ruiter, Gerrina; Zhao, Jun; Novello, Silvia; Miao, Liyun; Janne, Pasi A.; Goto, Koichi; Ruttinger, Dominik; Descamps, Tine; Brase, Jan Christoph; Bao, Weichao; Li, Rui; Brega, Nicoletta; Grassi, Paolo; Girard, Nicolas; Tan, Daniel Shao-Weng
errShare
errSave
Safety and efficacy of YK-029A in previously treated EGFR T790M-Mutant NSCLC: A multi-center phase I trial
errLung Cancer
IF4.4
err2025-09-23
err0
errOAAI
errXinyu Wu; Rui Wan; Lin Wu; Mingfang Zhao; Yanqiu Zhao; Xiumei Dai; Jun Zhao; Zhe Liu; Yanyan Xie; Yueyin Pan; Zhihong Zhang; Yu Yao; Kunyu Yang; Bi Chen; Jie Wang; Jianchun Duan
errShare
errSave
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
errNature Medicine
IF50
err2025-08-19
err0
PREAI
errShaodong Hong; Qiming Wang; Ying Cheng; Yongzhong Luo; Xiujuan Qu; Haibo Zhu; Zhenyu Ding; Xingya Li; Lin Wu; Yan Wang; Sheng Hu; Enwen Wang; Anwen Liu; Yuping Sun; Yun Fan; Feng Ye; Kaihua Lu; Jian Fang; Yuping Shen; Xiaoping Jin; Junyou Ge; Li Zhang; Wenfeng Fang
errShare
errSave
Comparison of the analgesic effects of ultrasound-guided erector spinae plane block and quadratus lumborum block: a systematic review and meta-analysis
errFrontiers in Pharmacology
IF4.8
err2025-08-02
err0
errOAAI
errLin Wu†; Weiyi Zhang†; Yiyong Wei; Donghang Zhang
errShare
errSave
First-line serplulimab plus chemotherapy in extensive-stage small-cell lung cancer: Updated results and biomarker analysis from the ASTRUM-005 randomized clinical trial
errCancer Communications
IF24.9
err2025-05-29
err0
errOAAI
errYing Cheng; Shuang Zhang; Liang Han; Lin Wu; Jun Chen; Peiyan Zhao; Hongmei Sun; Guilan Wen; Yinghua Ji; Anastasia Zimina; Jianhua Shi; Zhijie Pan; Jinsheng Shi; Xicheng Wang; Yuansong Bai; Tamar Melkadze; Yueyin Pan; Xuhong Min; Maksym Viguro; Xingya Li; Yanqiu Zhao; Junquan Yang; Tamta Makharadze; Ekaterine Arkania; Haoyu Yu; Jing Li; Fang Yang; Xinyi Yang; Chen Ling; Qingyu Wang; Yongqiang Shan; Jun Zhu; the ASTRUM-005 Study Group
errShare
errSave
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study
errSIGNAL TRANSDUCTION AND TARGETED THERAPY
IF52.7
err2025-05-23
err0
errOAAI
errXie, Mengqing; Bao, Minwei; Dong, Xiaorong; Wu, Lin; Liu, Li; Zhao, Jing; Chu, Xiangling; Wu, Yan; Ji, Xianxiu; Fang, Yujia; Yu, Xin; Zhang, Shiji; Wang, Qi; Hu, Tao; Wang, Jin; Zhu, Changbin; Su, Chunxia
errShare
errSave
Anlotinib Plus Docetaxel is Promising in Advanced NSCLC Progressing on First-Line Immunotherapy: A Pooled Analysis of Two Randomized Trials
errADVANCES IN THERAPY
IF4
err2025-05-12
err0
PREAI
errPu, XX; Shou, JW; Xiao, ZM; Chen, J; Xiao, ML; Guo, QY; Ma, ZX; Hong, W; Wang, QZ; Wang, YH; Li, J; Rao, CZ; Weng, J; Lu, LQ; Wu, L; Fang, Y
errShare
errSave
Potential biomarkers of primary resistance to first- and second-generation EGFR-TKIs in non-small-cell lung cancer: a real-world study
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2025-04-30
err0
errOAAI
errJingyi Wang; Bolin Chen; Xingxiang Pu; Jia Li; Yan Xu; Li Xu; Fang Xu; Kang Li; Yi Kong; Liyu Liu; Qianzhi Wang; Lin Wu
errShare
errSave
The high electron occupation on anti-bond orbital induced by the asymmetric covalent structure of C-S-N enhancing the oxygen reduction reaction
errJOURNAL OF POWER SOURCES
IF7.9
err2025-03-01
err0
PREAI
errWu, Lin; Ji, Chunyu; Li, Xueyan; Liu, Zirui; Yang, Hao; Qiu, Feng; Peng, Zhili; Liu, Qingju; Zhang, Longzhou
errShare
errSave
Hematoma, Perihematomal Edema, and Total Lesion Predict Outcome in Patients With Intracerebral Hemorrhage
errreligion brain behavior
IF2.7
err2025-02-18
err0
errOAAI
errHuang, Qin; Wu, Lin; Song, Ziwei; Zhang, Zhi; Kuang, Hongla; Zhu, Yuping; Zeng, Chenying; Zhang, Lanjiao; Zhang, Hudie; Xu, Zubing; Xu, Wenyuan; Lin, Jing
errShare
errSave
Brief Report: Ivonescimab Combined With Etoposide Plus Carboplatin as First-Line Treatment for Extensive-Stage SCLC: Results of a Phase 1b Clinical Trial
errJOURNAL OF THORACIC ONCOLOGY
IF20.8
err2025-02-01
err1
PREAI
errChen, Zhiwei; Wu, Lin; Wang, Qiming; Yu, Yan; Liu, Xianling; Ma, Rui; Li, Tao; Li, Yan; Song, Xia; Li, Lin; Zhao, Wei; Wang, Qiaoyun; Xu, Xiao
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
刘
刘忠范 (Zhongfan Liu)
H-index: 141 · Papers: 1.3K
Y
Yi‐Long Wu
H-index: 135 · Papers: 2.2K
T
Tony Mok
H-index: 131 · Papers: 1.1K
View more